Basic Information
Arixtra
67457-592
Regulatory Information
67457-592
NDA021345
C73594
June 8, 2020
USA
These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium injection), for subcutaneous useInitial U.S. Approval: 2001
HUMAN PRESCRIPTION DRUG LABEL
11
Company Information
790384502
Active Ingredients
SODIUM CHLORIDE
Code: 451W47IQ8X
Class Code: IACT
WATER
Code: 059QF0KO0R
Class Code: IACT
Active Moieties
FONDAPARINUX
Code: J177FOW5JL